# Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed

> **NCT05642481** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 16 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DIAGNOSTIC_TEST:** Therapeutic drug monitoring in plasma of mother and child and in breastmilk

## Key facts

- **NCT ID:** NCT05642481
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642481, "Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05642481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*